PMID: 6971014Sep 1, 1980Paper

Functional and developmental compartments of human T lymphocytes

Vox Sanguinis
P C Kung, G Goldstein

Abstract

Hybridoma technology has made it possible to prepare a range of antibodies which define developmental and functional compartments of the T lymphocyte lineage in man. The feasibility of achieving this aim, and some immediate clinical applications, are illustrated in this report on seven monoclonal antibodies from seven selected hybridoma clones, which are shown to define subclasses of human T cells according to their immune function and developmental rank.

References

May 10, 1979·The New England Journal of Medicine·E L ReinherzS F Schlossman
Nov 8, 1979·The New England Journal of Medicine·E L ReinherzS F Schlossman
Nov 22, 1979·The New England Journal of Medicine·G TosatoM Blaese
Jan 1, 1977·Cold Spring Harbor Symposia on Quantitative Biology·H Cantor, E A Boyse
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·A J StrelkauskasS F Schlossman
Aug 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman
Jan 1, 1977·Contemporary Topics in Immunobiology·L Chess, S F Schlossman
Mar 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman
Aug 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·R A HoffmanG Goldstein
Jan 1, 1980·Journal of Supramolecular Structure·G Goldstein, C Y Lau

❮ Previous
Next ❯

Citations

Nov 1, 1986·Journal of Clinical Immunology·B T Shannon, W A Newton
Jan 1, 1986·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·P YouinouC Ferec
Dec 30, 1982·Journal of Immunological Methods·M K HoffmannR S Mittler
Feb 10, 1984·Journal of Immunological Methods·P J BuckleyW S Walker
Jan 1, 1981·International Journal of Immunopharmacology·P C KungG Goldstein
Jan 1, 1981·International Journal of Immunopharmacology·C L BergerR L Edelson
Jan 1, 1987·International Journal of Immunopharmacology·G VerbruggenE M Veys
Jun 8, 1983·The New Zealand Medical Journal·M E BeardD N Hart
Oct 1, 1990·Immunology and Cell Biology·M J RuddJ W Halliday
Mar 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·T W ChangG Goldstein
Jul 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·C D Platsoucas, R A Good
Feb 1, 1982·Environmental Health Perspectives·E R Heise
Feb 1, 1988·Immunology Letters·C R GattassM M Bunn-Moreno
Jan 1, 1987·Immunopharmacology and Immunotoxicology·L DenesL Kisfaludy
Jan 1, 1984·Journal of Immunopharmacology·A D CrockardK T Ennis
Mar 1, 1982·Journal of the American Academy of Dermatology·A ChuR L Edelson
Jan 1, 1985·Leukemia Research·R SeshadriA A Morley
Dec 1, 1983·Journal of Cutaneous Pathology·C L Berger, R L Edelson
Dec 1, 1983·Journal of Cutaneous Pathology·P C Kung
Mar 1, 1983·International Journal of Dermatology·P C KungR L Edelson
Mar 1, 1986·British Journal of Haematology·A E IrvineJ M Bridges
Feb 1, 1986·The Journal of Pathology·M A PirisC Rubio
Jan 1, 1983·Archives of Dermatological Research·J D BosR H Cormane
Nov 1, 1982·European Journal of Immunology·L ChatenoudJ F Bach
May 1, 1983·Scandinavian Journal of Haematology·A Crockard, D Catovsky
Mar 27, 2001·Transplantation Proceedings·S Lederman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.